Kun Wang
Impact in
- Pathology and Forensic Medicine top 0.5%
- Spine and Intervertebral Disc Pathology
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 60
- Cancer Immunotherapy and Biomarkers 17
- HER2/EGFR in Cancer Research 11
- Cancer Treatment and Pharmacology 11
- Co-authors
- Yang Cao (33 shared papers)Yu Song (29 shared papers)Yukun Zhang (25 shared papers)Shuai Li (26 shared papers)Xinghuo Wu (20 shared papers)Zhiwei Liao (16 shared papers)Rongjin Luo (15 shared papers)Kangcheng Zhao (12 shared papers)
- Journals
- Annals of Oncology (8 papers)Journal of Clinical Oncology (7 papers)Oncotarget (6 papers)Oxidative Medicine and Cellular Longevity (5 papers)Frontiers in Oncology (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Kun Wang
258 papers receiving 5.7k citations
Kun Wang's Hit Papers
Peers
Comparison fields: 5 of 143
- Pathology and Forensic Medicine 1.1k
- Cancer Research 818
- Radiology, Nuclear Medicine and Imaging 620
- Oncology 724
- Nephrology 187
Countries citing papers authored by Kun Wang
This map shows the geographic impact of Kun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Wang more than expected).
Fields of papers citing papers by Kun Wang
This network shows the impact of papers produced by Kun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Wang. The network helps show where Kun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 284 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study Hit paper breakdown → | 2019 | 370 |
| 2 | Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis Hit paper breakdown → | 2022 | 237 |
| 3 | 2020 | 165 | |
| 4 | 2018 | 161 | |
| 5 | 1995 | 152 | |
| 6 | 2021 | 118 | |
| 7 | 2021 | 115 | |
| 8 | 2023 | 115 | |
| 9 | Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study Hit paper breakdown → | 2023 | 107 |
| 10 | 2020 | 106 | |
| 11 | 2019 | 104 | |
| 12 | 2019 | 85 | |
| 13 | 2019 | 79 | |
| 14 | 2016 | 76 | |
| 15 | 2019 | 74 | |
| 16 | 2013 | 63 | |
| 17 | 2005 | 62 | |
| 18 | 2019 | 62 | |
| 19 | 2021 | 62 | |
| 20 | 2020 | 60 |
About Kun Wang
Kun Wang is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 284 papers that have together received 5.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (30 papers), Spine and Intervertebral Disc Pathology (21 papers), Cancer Immunotherapy and Biomarkers (17 papers), Acute Kidney Injury Research (14 papers), HER2/EGFR in Cancer Research (11 papers), Immunotherapy and Immune Responses (11 papers), Cancer Treatment and Pharmacology (11 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Cancer Research (818 citations), Radiology, Nuclear Medicine and Imaging (620 citations), Oncology (724 citations) and Nephrology (187 citations). Kun Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yang Cao, Yu Song, Yukun Zhang, Shuai Li, Xinghuo Wu, Zhiwei Liao, Rongjin Luo, Kangcheng Zhao, Gaocai Li and Wenbin Hua. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Oncotarget, Oxidative Medicine and Cellular Longevity and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.